Alana B. McNulty - 20 Jun 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Business Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Alana B. McNulty
Issuer symbol
EFTR
Transactions as of
20 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 16:19:51 UTC
Previous filing
16 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 20 Jun 2022 Common Stock 150,000 $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.